HOME / NEWS & PERSPECTIVES / Fertility

News, stories & opinions for the world’s healthtech innovators.

Fertility

IVF pioneer Genea sells for more than $250 million

Australian fertility group Genea has been successfully sold to an Asian consortium for more than AU$250 million after disrupting the fertility industry with a range of new IVF technologies.

Markets.

Diagnostics

Life Sciences

Cell & Gene Therapy

Medical Devices

Topics.

Opinion

Awards

Digital Health

Commercialization

Point-of-Care

Ventures

Corporate

Software

COVID-19

People & Culture

Lumos Diagnostics

Innovation

Fertility

Entrepreneurship

Energy

Automation

Sign up for the Perspectives newsletter:

World first baby born using the Geri incubator

In a world first, a baby girl has been born using the specially-designed imaging incubator, Geri, developed and commercialized by Genea and Planet Innovation.

Planet Innovation recognized for world leading product design

Planet Innovation clients pick up four trophies and Best Overall Product Design at the Good Design Awards.

Genea’s IVF deal with Merck secures manufacturing contract for PI

Pharmaceutical giant Merck Serono has signed an exclusive deal securing global marketing and commercialization rights to Genea Biomedx’s range of IVF products including Gavi and Geri, which were designed by Genea with development partner, Planet Innovation.

World first imaging incubator uses unconventional approach to monitor embryos

Genea Biomedx has created an incubation instrument with time lapse photography, which allows scientists and potential parents to watch their embryos grow in their first crucial few days.

Genea CEO: From idea to Product of the Year

Tomas Stojanov has been an integral part of an extremely successful network of invitro-fertilisation (IVF) clinics in his role as the CEO of fertility group Genea, but his personal dream is to do more. He wanted to change the world of IVF to benefit his company, his industry and most importantly his patients.

How Genea changed the world of IVF through automation

Despite 30 years of IVF practice the process of freezing human embryos, known as vitrification, has remained extremely manual and susceptible to errors and inconsistencies by embryologists. In 2009, Genea Biomedx teamed up with Planet Innovation to solve this challenge by automating IVF vitrification and finally making the process consistent and standardised for labs around the world.

The secret behind the consumable ‘pod’ that pioneered IVF automation

PI Executive Director Eduardo Vom reveals the details to the microfluidic pod that was developed for the Gavi instrument to enable automated IVF vitrification for the first time in the world.